2-Hydroxypropyl-beta-cyclodextrin
"2-Hydroxypropyl-beta-cyclodextrin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivative of beta-cyclodextrin that is used as an excipient for steroid drugs and as a lipid chelator.
Descriptor ID |
D000073738
|
MeSH Number(s) |
D04.345.103.333.500 D09.301.915.400.375.333.500 D09.698.365.855.400.375.333.500
|
Concept/Terms |
2-Hydroxypropyl-beta-cyclodextrin- 2-Hydroxypropyl-beta-cyclodextrin
- 2 Hydroxypropyl beta cyclodextrin
- beta-Hydroxypropylcyclodextrin
- beta Hydroxypropylcyclodextrin
- HPbetaCD
- Hydroxypropyl Betadex
- Betadex, Hydroxypropyl
- HP-beta-CD
- 2 Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl beta cyclodextrin
|
Below are MeSH descriptors whose meaning is more general than "2-Hydroxypropyl-beta-cyclodextrin".
Below are MeSH descriptors whose meaning is more specific than "2-Hydroxypropyl-beta-cyclodextrin".
This graph shows the total number of publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in this website by year, and whether "2-Hydroxypropyl-beta-cyclodextrin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 0 | 1 |
2020 | 1 | 2 | 3 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in Profiles.
-
Low Risk Profile of Long-Term Repeated Lumbar Puncture for Intrathecal Delivery of 2-Hydroxypropyl-Beta-Cyclodextrin in Patients With Niemann-Pick Type C. Pediatr Neurol. 2023 07; 144:99-103.
-
Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1. Genet Med. 2023 03; 25(3):100349.
-
Application of a glycinated bile acid biomarker for diagnosis and assessment of response to treatment in Niemann-pick disease type C1. Mol Genet Metab. 2020 12; 131(4):405-417.
-
Anesthetic management of pediatric patients with Niemann-Pick disease type C for intrathecal 2-hydroxypropyl-?-cyclodextrin injection. Paediatr Anaesth. 2020 07; 30(7):766-772.
-
Application of N-palmitoyl-O-phosphocholineserine for diagnosis and assessment of response to treatment in Niemann-Pick type C disease. Mol Genet Metab. 2020 04; 129(4):292-302.
-
Intrathecal 2-hydroxypropyl-?-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. Lancet. 2017 Oct 14; 390(10104):1758-1768.